How cabozantinib improves survival in rare cancer patients :

Neuroendocrine tumors are a rare type of cancer that starts in neuroendocrine cells – cells that have both nerve and hormone functions.

Related Keywords

, National Clinical Trials Network , Drug Administration , National Cancer Institute , Cabozantinib , Neuroendocrine Tumors , Cancer Research , Cancer Patients , Drug Studies ,